New drugs raise hopes of pancreatic cancer breakthrough
Pancreatic cancer remains one of the most aggressive forms of the disease, with survival rates still alarmingly low, but recent advances in experimental treatments are offering cautious hope to patients and researchers.
According to studies, only around one in 10 people diagnosed with Pancreatic cancer survive more than five years, and incidence rates are rising globally, particularly among younger adults. The disease is projected to become the second deadliest cancer in developed countries, behind lung cancer.
Despite decades of limited progress, researchers say increased funding and scientific focus in recent years are beginning to yield results. Patrick Mehlen of the Leon Berard Cancer Centre said there had not been “any medical progress for 40 years,” but added that growing inves...










